The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including an | Immunology ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...

Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...

WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...

Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...

A NEW mum who wanted a new bust after having her baby has lost all of her hair following the operation – including her eyelashes and eyebrows. The silicone implants Czech dental worker ...

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

BMO Capital Markets adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotechnology firm's stock rating from Outperform to Market Perform, accompanied by a significant decrease in ...

Roz Purcell has shared her best advice for fellow alopecia areata sufferers after she revealed 'another bald patch popped up ...